Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000465172 | SCV000546551 | pathogenic | Beckwith-Wiedemann syndrome | 2016-12-24 | criteria provided, single submitter | clinical testing | This sequence change deletes 2 nucleotides from exon 2 of the NSD1 mRNA (c.880_881delGA), causing a frameshift at codon 294. This creates a premature translational stop signal (p.Glu294Ilefs*19) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, loss-of-function variants in NSD1 are known to be pathogenic (PMID: 12807965, 15942875, 17565729). For these reasons, this variant has been classified as Pathogenic. |
Labcorp Genetics |
RCV003231492 | SCV001585846 | pathogenic | Sotos syndrome | 2016-12-24 | criteria provided, single submitter | clinical testing | This sequence change deletes 2 nucleotides from exon 2 of the NSD1 mRNA (c.880_881delGA), causing a frameshift at codon 294. This creates a premature translational stop signal (p.Glu294Ilefs*19) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, loss-of-function variants in NSD1 are known to be pathogenic (PMID: 12807965, 15942875, 17565729). For these reasons, this variant has been classified as Pathogenic. |